News

Mike Honious Boosts DeepFabric's Supply Chain Ambitions

Mike Honious Boosts DeepFabric's Supply Chain Ambitions

DeepFabric Taps Supply Chain Veteran Mike Honious

Remember when logistics was just a fancy word for moving stuff from A to B? Not anymore, my friends. Enter DeepFabric, a player trying to shake up the supply chain with a mix of AI mojo and some good old-fashioned industry grit. And who better to help them dig in than Mike Honious, fresh off a hefty 20-year stint at GEODIS as their bigwig in the Americas? Now, he's bringing his hard-earned chops to DeepFabric as a Strategic Advisor, diving headlong into the AI waters. This ain't just a splash; it's a cannonball.

From Logistics Leader to AI Advocate

For those of you unacquainted, Honious was the guy at GEODIS who had his fingerprints all over their logistics operations—contract logistics, transportation management, you name it. He's been around the block, and folks in the industry know that carrying the baton at GEODIS is no small feat. Since stepping away from his CEO role in 2025, Honious has been busy with his brewery and tavern back home in Tennessee, but you can bet he was just itching for the next big gig.

"I know from experience how much trust it takes for an operations team to change the way they work. What I've seen from Kalyan and this team is a group that respects that trust, building tools people actually want to use instead of ones forced on them," said Mike Honious.

Happy Hour Meets High-Tech

Now, here’s where it gets interesting. Honious is teaming up with DeepFabric for their very first Supply Chain AI Happy Hour in Hendersonville. Talk about merging business with pleasure. It’s taking place at his own Half Batch Brewing— yes, the same spot that snagged some golden accolades at the Great American Beer Festival. This event isn't just about knocking back a cold one; it's about wrapping your head around AI in supply chains and rubbing elbows with fellow pros from Nashville and beyond. That's called bringing down the stiff boardroom wall and cheers to that.

Impact on DeepFabric's Roadmap

With Honious in their corner, DeepFabric isn't just pinning hopes on fancy tech demos to catch eyes. As Founder and CEO Kalyan Kommineni put it, having Honious behind the wheel gives them the edge they need to craft tech operators will actually trust and want to use. That's not just sweet talk—it's about grounding pie-in-the-sky ambitions with on-the-ground realities.

It's no accident this comes hot on the heels of Kenco, a reliable name in 3PL, announcing its roll-out of DeepFabric's AI agents across several operational fronts. Tennessee might just be the jumping-off point for something much bigger. It looks like Honious and DeepFabric see eye to eye on the potential here for expanding AI use in major logistics hubs. This isn't just a toe in the water; it's about riding bigger waves.

The Broader Implications

Okay, let's cut to the chase. The logistics realm has always played second fiddle to tech when it comes to glam. But the reality check folks need is this: supply chain efficiency isn't just a buzzword, it's a heavy hitter on the balance sheet. What DeepFabric and Honious are cooking up could very well shift that paradigm by making AI an unmissable part of the supply chain toolkit. This shift is about more than handling goods; it's about mastering processes that keep profits steaming ahead even when hiccups happen.

Sure, DeepFabric's not a household name (yet), but sharpen your pencils, because if they're smart about it—and with Honious steering his advisory role—they're setting themselves up nicely to leave a mark. They've got heavy hitters already onboard like HelloFresh and Weber Logistics. The wild card? Just how fervently the industry embraces these newfangled AI agents. That's where anyone with skin in this game needs to keep a close watch.

What to Watch Next

So, what’s the next move? Keep an eye on how Honious’s involvement affects DeepFabric’s trajectory. If they’re able to marry the tech and the tactical with Honious’s expertise, we could be in for one heck of a ride. Those supply chain AI agents are either going to catch fire or fizzle out, but if they do catch, expect some disruptive change in how logistics is done.

In the meantime, DeepFabric's averaging out their chances with Honious's steadiness, aiming to prove AI's value in real-world ops and not just in some virtual simulation. Here's hoping they pour us another round of good news post this happy hour integration.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Stretch Zone Expands Horizons with Canadian Studio Launch

Updated Category News Views 214

Stretch Zone's Exciting New Chapter in Canada Stretch Zone, a trailblazer in the realm of assisted stretching, has embarked on a significant milestone by opening its first studio in Canada. This new location is not just a store but a powerful symbol of the brand's commitment to enhance flexibility and mobility in communities beyond the United States. The Vision Behind the...

Continue Reading
Eilean Therapeutics Unveils Groundbreaking JAK2 Inhibitor ZE74-0282

Updated Category News Views 585

New Frontiers in JAK2 Inhibition by Eilean Therapeutics Eilean Therapeutics LLC, a pioneering biotechnology company, is set to make waves in cancer treatment with its latest development, ZE74-0282, a wild-type-sparing JAK2-JH2/V617F inhibitor. The company has announced an exciting presentation at the upcoming American Society of Hematology (ASH) Annual Meeting, focusing...

Continue Reading
PodcastOne Extends LadyGang Contract as It Approaches 1000 Episodes

Updated Category News Views 116

PodcastOne Renews its Agreement with LadyGang Podcast PodcastOne, a key player in the podcasting world, is thrilled to announce the renewal of its contract with the immensely popular LadyGang podcast, hosted by Keltie Knight, Becca Tobin, and Jac Vanek. Launched in 2015 on PodcastOne, this engaging podcast has resonated with millions of listeners and is gearing up to...

Continue Reading
BCA Research Warns Upcoming Rate Cuts May Be Insufficient

Updated Category News Views 73

BCA Research Warns Rate Cuts May Arrive Too Late BCA Research has expressed concerns about the upcoming rate cuts, suggesting they might not effectively address a potential recession. The firm points out that the effects of monetary policy often lag, meaning the economy is still grappling with the repercussions of previous tightening measures. Market Sentiments and...

Continue Reading
SOMOS Pilates Nashville: A Vibrant Rebranding Journey

Updated Category News Views 235

SOMOS Pilates Nashville: A Vibrant Rebranding Journey In an inspiring shift, Studio Pilates Nashville has announced its rebranding as SOMOS Pilates Nashville. This transition marks a significant evolution, aimed at celebrating the studio's growth and commitment to community-centered movement practices. Welcoming a New Identity The rebranding initiative reveals more than...

Continue Reading